We are live on ! Find out more
IXHL icon

Incannex Healthcare

12 hedge funds and large institutions have $220K invested in Incannex Healthcare in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

100% more funds holding

Funds holding: 612 (+6)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

1.09% more ownership

Funds ownership: 0%1.09% (+1.1%)

35% less capital invested

Capital invested by funds: $339K → $220K (-$119K)

Holders
12
Holders Change
+6
Holders Change %
+100%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
2
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

IXHL Hedge Fund Activity: Q2 2025 in Review

12 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in Incannex Healthcare (IXHL) for Q2 2025, worth a combined $220K — down 35% from $339K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new IXHL positions and 2 closed out — a net gain of 6 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was LPL Financial, opening a new position worth an estimated $107K. The largest seller was Citadel Advisors, exiting entirely with an estimated $69.6K sold.

  • 12 institutional investors held Incannex Healthcare (IXHL) as of Q2 2025, up from 6 in Q1 2025.
  • Funds reported $220K of Incannex Healthcare stock for Q2 2025, down 35% quarter-over-quarter.
  • 8 funds opened new Incannex Healthcare positions in Q2 2025 and 2 closed out, a net change of +6 holders.
  • The largest Incannex Healthcare buyer in Q2 2025 was LPL Financial, an estimated $107K added.
  • The largest Incannex Healthcare seller in Q2 2025 was Citadel Advisors, an estimated $69.6K sold.

Based on aggregated 13F filings for Q2 2025.